Spectra Laboratories broke ground on a 200,000-square-foot laboratory in Southaven, Mississippi yesterday. The project is expected to create more than 300 jobs over the next three years.
Underlying business development in line with expectations; Continued strong organic revenue growth; Healthy growth in the U.S. dialysis business
Fresenius Medical Care is pleased the U.S. Administration’s plans for changing the way care is provided to people with kidney disease supports its existing strategy.
Fresenius Medical Care North America (FMCNA) has announced an investment in BioIntelliSense, a Denver-based company that is developing a medical grade data services platform for continuous remote...
Press Release Fresenius Medical Care successfully places USD bonds Fresenius Medical Care, the world’s largest provider of dialysis products and services, yesterday successfully placed bonds with an...
Fresenius Medical Care, the world’s largest provider of dialysis products and services, today announced that Standard & Poor’s has upgraded Fresenius Medical Care’s corporate credit rating to BBB with a stable outlook from BBB- with a positive outlook.
